Tissue engineered perivascular endothelial cell implants regulate vascular injury.
Molecular biomaterial engineering permits in vivo transplantation of cells and tissues, offering the promise of restoration of physiologic control rather than pharmacologic dosing with isolated compounds. We engrafted endothelial cells on Gelfoam biopolymeric matrices with retention of viability, no...
שמור ב:
| הוצא לאור ב: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
National Academy of Sciences
1995
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC41109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7667257/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.18.8130 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|